1Yamaguchi K,Kinosaki M,Goto M,et al.Characterization of structural domain of human osteoclastogenesis inhibitory factor〔J〕[].Journal of Biological Chemistry.1998
2Tsuda E,Goto M,Mochizuki S,et al.Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis〔J〕[].Biochemical and Biophysical Research Communications.1997
3Morinaga T,Nakagawa N,Yasuda H,et al.Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor〔J〕[].European Journal of Biochemistry.1998
4Lacey DL,Timms E,Tan TL,et al.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation〔J〕[].Cell.1998
5Brandstrom H,Jonsson KB,Ohlsson C,et al.Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells 〔J〕[].Biochemical and Biophysical Research Communications.1998
6Takai H,Kanematsu M,Yano K,et al.Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells〔J〕[].Journal of Biological Chemistry.1998
7Yasuda H,Shima N,Nakagawa N,et al.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL〔J〕[].Proceedings of the National Academy of Sciences of the United States of America.1998
8Hofbauer LC,Dunstan CR,Spelsberg TC,et al.Osteoprotegerin production by human osteoblast lineage cells in stimulated by vitamin D, bone morphogenetic protein-2, and cytokines 〔J〕[].Biochemical and Biophysical Research Communications.1998
9Yasuda H,Shima N,Nakagawa N,et al.Identity of osteoclastogenesis inhibitory factor(OCIF)and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro〔J〕[].The Journal of Endocrinology.1998
10Akatsy T,Murakami T,Nishikawa M,et al.Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast 〔J〕[].Biochemical and Biophysical Research Communications.1998
7Murphy MG,Cerchio K,Stoch SA,et al.Effect of L-000845704,an alpha Vbeta3 integrin antagonist,on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.J Clin Endocrinol Metab 2005;90(4):2466-8
8Zhang ZZ,Chen JT,Jin DD.Platelet derived growth factor(PDGF)-BB stimulates osteoclastic bone resorption directly:the role of receptor beta.Biochem Biophys Res Commun 1998;251:190-4
9Fan X,Roy E,Zhu L,et al.Nitric oxide regulates receptor activator of nuclear factor-κB ligand and osteoprotegerin expression in bone marrow stromal cells.Endocrinology 2004; 145(2):751-9
